Cordyceps Sunshine Biotech Holdings Co., Ltd. Operating Lease, Right-of-Use Asset, Amortization Expense
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $86.22 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2024-07-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2024-07-05
- Cordyceps Sunshine Biotech Holdings Co., Ltd. operating lease, right-of-use asset, amortization expense for the quarter ending 2023-12-31 was $118.32K.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|
| 2023-12-31 | $118.32K derived: 20-F 12 month − 6-K 9 month · filed 2024-07-05 | $86.22K 20-F · filed 2024-07-05 | |
| 2023-09-30 | -$32.11K 6-K · filed 2023-11-13 | ||
| 2022-12-31 | $56.67K 20-F · filed 2024-07-05 | ||
| 2021-12-31 | $4.93K 20-F · filed 2024-07-05 |